Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer - Lecia V. Sequist, Panos M. Fidias, Jennifer S. Temel, Tatjana Kolevska, Michael S. Rabin, Ralph V. Boccia, Howard A. Burris, Robert J. Belt, Mark S. Huberman, Ostap Melnyk, Glenn M. Mills, Craig W. Englund, David C. Caldwell, James G. Keck, Lisa Meng - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Elsevier, Journal of Thoracic Oncology, 11(4), p. 1389-1396, 2009

DOI: 10.1097/jto.0b013e3181b6b84b

Links

Tools

Export citation

Search in Google Scholar

Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer

Journal article published in 2009 by Lecia V. Sequist, Panos M. Fidias, Jennifer S. Temel, Tatjana Kolevska, Michael S. Rabin, Ralph V. Boccia, Howard A. Burris, Robert J. Belt, Mark S. Huberman, Ostap Melnyk, Glenn M. Mills, Craig W. Englund, David C. Caldwell, James G. Keck, Lisa Meng and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO